The ASA Biopharmaceutical Section is pleased to announce the following webinar, presented by Dr. Danyu Lin on February 9, 2022.
Title: Durability of Covid-19 Vaccines
Speakers: Danyu Lin, Ph.D.
Dennis Gillings Distinguished Professor, Department of Biostatistics, University of North Carolina at Chapel Hill
Date and Time: February 9, 2022, 11:00 to 12:00 pm Eastern Time
Registration Link: Durability of Covid-19 Vaccines Tickets, Wed, Feb 9, 2022 at 11:00 AM | Eventbrite
Abstract: Evaluating the durability of protection afforded by Covid-19 vaccines is a public health priority, with the results needed to inform policies around booster vaccinations as well as those around non-pharmaceutical interventions. In this talk, I will present a general framework for estimating the effects of Covid-19 vaccines over time in phase 3 clinical trials and observational studies. I will show some results on the duration of vaccine protection from the Moderna pivotal trial and from the North Carolina statewide surveillance data. The latter data, which were published in the New England Journal of Medicine in January, provided rich information about the effectiveness of the Pfizer, Moderna, and Johnson & Johnson vaccines in reducing the risks of Covid-19, hospitalization, and death over time. I will discuss the implications of these results for booster vaccinations.
Presenter: Dr. Lin is an internationally recognized biostatistician who has made many fundamental contributions to the designs and analysis of medical and public health studies. He has published over 250 peer-reviewed papers in leading statistical and medical journals. Dr. Lin received the Mortimer Spiegelman Gold Medal from the American Public Health Association in 1999 and the George W. Snedecor Award from the Committee of Presidents of Statistical Societies in 2015. He is an Fellow of IMS and ASA and an Associate Editor of Biometrika and JASA. He is currently interested in evaluating the efficacy of treatments and vaccines for Covid-19.
If you have any question about the registration, please contact Wei (Michelle) Zhang (michelle.zhang@affamed.com).
------------------------------
Wei (Michelle) Zhang
VP, Head of Biometrics
AffaMed Therapeutics
------------------------------